INTRODUCTION
Many environmental stimuli including cytokines, UV radiation, chemotherapeutic agents and even growth factor generate high levels of reactive oxygen species that can perturb the normal redox balance and shift cells into a state of oxidative stress. When the stress is severe, survival is dependent on the ability of a cell to adapt to or resist the stress. Alternatively, cells may respond to the stress by undergoing apoptosis [1] . Among the main survival-signalling pathways and\or central mediators activated in response to oxidant injury are the extracellular signal-regulated kinase (ERK)-signalling cascades, p53 activation, phosphoinositide 3-kinase (PI-3K)\Akt pathway, nuclear factor κB signalling system and the heat-shock response [1] [2] [3] [4] [5] [6] . Also, growth factor receptors play an important role in initiating cellular responses to oxidative stress [7] [8] [9] [10] . Certain proliferationassociated signalling pathways, including those leading to activation of ERK and Akt, are activated by oxidative stress in a growth-factor receptor-dependent manner [7] . Thus some signalling pathways involved in regulating proliferation also participate in the cellular response to oxidative stress.
Phospholipase C-γ1 (PLC-γ1) is known to be activated in response to growth-factor stimulation by a mechanism that relies on tyrosine phosphorylation and plays an important role in regulating cell proliferation and differentiation by the generation of the second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate, leading to the activation of protein kinase C (PKC) and increased levels of intracellular calcium, respectively
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that of the wild-type cells. Furthermore, pretreatment of Plcg1 +/+ cells with PKC-specific inhibitor decreased levels of PKCdependent Bcl-2 phosphorylation, enhanced caspase-3 activity and their sensitivity to H # O # . On the contrary, treatment of Plcg1 −/− cells with PKC-specific activator increased the Bcl-2 phosphorylation, decreased caspase-3 activity and improved their survival. These results suggest that PLC-γ1 mediates survival signalling in oxidative-stress response by PKC-dependent phosphorylation of Bcl-2 and inhibition of caspase-3.
Key words : apoptosis, Bcl-2, caspase-3, phosphorylation, signal transduction. [11] [12] [13] [14] . Recently, an anti-apoptotic role of PLC-γ1 activation in oxidative stress has been reported in mouse embryo fibroblasts (MEF) [15] . The study demonstrated that PLC-γ1 was tyrosinephosphorylated following H # O # treatment and PLC-γ1 deficient MEF showed more sensitivity to H # O # than wild types. However, the downstream targets of PLC-γ1 activation that are involved in mediating stress resistance remain to be identified.
PKC is known as a key enzyme in several signal-transduction pathways and is involved in the regulation of numerous cellular functions [16] . Some PKC isoenzymes play an anti-apoptotic role under some stress applications by phosphorylation of Bcl-2 [17] [18] [19] and inhibition of caspase-3 activity [20] [21] [22] . Considering that PKC is a downstream of PLC-γ1 in mitogenic signalling and is also activated in oxidative stress [23] [24] [25] , we studied the role of PKC pathway in oxidative stress by using MEF that have been rendered deficient for PLC-γ1 (Plcg1 −/− ) by targeted disruption of both plc-γ1 alleles and its wild type (Plcg1 +/+ ) as a model system [26, 27] . The results showed that PKC-dependent phosphorylation of Bcl-2 and caspase-3 inhibition are involved in PLC-γ1 survival signalling following oxidative stress.
EXPERIMENTAL Materials
Dulbecco's modified Eagle's medium and bovine foetal serum were from Gibco BRL (Gaithersburg, MD, U.S.A.). Antibodies specific to PLC-γ1, phosphotyrosine, Bcl-2, caspase-3 and ECL2 Western-blotting detection system were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A. 
Cell culture and treatment
Immortalized Plcg1 −/− and Plcg1 +/+ cells were established by Ji and co-workers [26, 27] . Both cell lines were cultured in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) foetal bovine serum and 1 % (v\v) antibiotics mixture in a humidified 95 % air, 5 % CO # atmosphere. Cells were stimulated by H # O # at 37 mC with gentle stirring at various concentrations (0.05, 0.2, 0.5, 1 or 5 mM).
Immunoprecipitation and immunoblotting
Stimulated cells (1i10( cells\ml) were lysed in ice-cold lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 % (v\v) Nonidet P-40, 100 µM Na $ VO % , 2 mM PMSF, 10 µg\ml leupeptin, 10 µg\ml aprotinin). Clear samples of lysates were obtained by centrifugation at 12 000 g for 10 min at 4 mC. The supernatants were incubated sequentially (1 h for each incubation) with antibodies and Protein A-Sepharose at 4 mC. Wholecell lysate or immunoprecipitates were analysed by SDS\PAGE and transferred electrophoretically to PVDF membranes. Blots were probed with the indicated antibodies and immunoreactive proteins were revealed by the ECL2 system.
PLC assay
Cells cultured in 100 mm dishes were serum-starved for 12 h in inositol-free medium supplemented with myo- [2- 
PKC kinase assay
PKC assay was performed by using the PKC assay system according to the manufacturer's recommendations. Briefly, 5i10'k1i10( stimulated cells were washed and homogenized by using a cold homogenizer in 0.5 ml of cold extraction buffer [25 mM Tris\HCl, pH 7.4; 0.5 mM EDTA; 0.5 mM EGTA; 0.05 % (v\v) Triton X-100; 10 mM β-mercaptoethanol, supplemented with the protease inhibitors PMSF (0.5 mM), leupeptin (1 µg\ml), aprotinin (1 µg\ml)]. The lysates were centrifuged at 14 000 g for 5 min and the supernatant was applied to a 1 ml DEAE-cellulose anion-exchange chromatography column. Bound PKC was eluted batchwise with 5 ml of extraction buffer containing 200 mM NaCl. Then, 5 µl of the eluate (enzyme sample) was added to the reactants containing 5 µl of PKC coactivation buffer (five times) (1.25 mM EGTA, 2 mM CaCl # , 0.5 mg\ml BSA), 5 µl of activation buffer (five times) (1.6 mg\ml phosphatidylserine, 0.16 mg\ml DAG, 100 mM Tris\HCl, pH 7.5, 50 mM MgCl # ), 5 µl biotinylated peptide substrate (Neurogranin, AAKIQAS*FRGHMARKK, where * indicates the biotinylated amino acid) and 5 µl of [γ-$#P]ATP mix (0.5 mM ATP, 100 µCi\ml) per tube and incubated at 30 mC for 5 min. After termination by 7.5 M guanidinium chloride, 10 µl of the reaction mixture was spotted on to SAM Biotin Capture Membrane (Promega). The membrane was washed with 2 M NaCl for less than 20 min and PKC activity was quantified by liquidscintillation counting.
ERK1/ERK2 assay
ERK1\ERK2 was performed by using non-radioactive kits manufactured by Cell Signaling Technology according to the manufacturer's recommendations. Briefly, activated ERK was precipitated from cell lysates by using anti-phospho-ERK1\ERK2 (Thr#!#\Tyr#!%) antibody, and precipitates were incubated with a specific substrate Elk-1 and ATP. The reaction was terminated by adding boiling gel loading buffer. ERK activity was detected by immunoblotting the products of the kinase reaction with anti-phospho-Elk (Ser$)$) antibody.
Phosphorylation of Bcl-2
Cells were labelled with [$#P]orthophosphoric acid and Bcl-2 proteins were immunoprecipitated by using Bcl-2 antibody. Immunoprecipitates were analysed by SDS\PAGE and transferred to PVDF membranes, then exposed to Kodak X-Omat film for 16 h at k80 mC. The same blot was then used to perform immunoblotting analysis with the anti-Bcl-2 antibody.
Caspase-3 enzyme activity
For detection of caspase-3 activity, 1i10' cells were lysed, followed by centrifugation. Caspase-3 activity was detected in the resulting supernatants by measuring the proteolytic cleavage of the fluorogenic substrate Asp-Glu-Val-Asp-7-amino-4 methyl coumarin and 7-amino-4-methyl coumarin as standard in assay buffer by using an excitation wavelength of 380 nm and an emission wavelength of 460 nm. Figure  1A) . The time course of PLC-γ1 activation was determined by Figure 1B ). PLC-γ1 activity started increasing 2 min after H # O # treatment, reached a maximum after 5 min (3-fold increase over basal state) and decreased to basal levels after 20 min. Addition of 5 µM herbimycin A, a specific protein tyrosine kinase (PTK) inhibitor, completely abolished the activation of PLC-γ1, but pretreatment with 100 nM wortmannin, a PI-3K inhibitor, had no effect on PLC-γ1 activation ( Figures 1A and 1B) . Next, we tested whether H # O # could induce tyrosine phosphorylation of PLC-γ1. Immunoprecipitation of PLC-γ1 after H # O # treatment and subsequent Western blotting with an anti-phosphotyrosine antibody revealed that phosphorylation of PLC-γ1 is initiated on treatment with 50 µM H # O # and reaches a maximum with 1 mM H # O # ( Figure 1C) . Also, PLC-γ1 phosphorylation started increasing after 2 min when treated with 200 µM H # O # , was maximum after 5 min and remained at higher than basal levels after 20 min ( Figure 1D ). These results showed that PLC-γ1 was phosphorylated and activated by H # O # treatment in a dose-and time-dependent manner by a PTK-dependent and PI-3K-independent mechanism.
Cell viability analysis

PKC is activated in a PLC-γ1-dependent manner by treatment with low doses of H 2 O 2
PLC-γ1 may regulate PKC activity by DAG and Ca# + [28] . In this study, we examined the role of PLC-γ1 in the activation of PKC pathway in fibroblasts exposed to oxidative stress. Wildtype or PLC-γ1-deficient cells were treated with various concentrations of H # O # , and the cell extract was subjected to kinase assay as described in the Experimental section. In wild-type cells, PKC activity increased rapidly and reached a maximum 10 min after stimulation with 200 µM H # O # , whereas activation of PKC in PLC-γ1-deficient cells was completely abolished (Figure 2A ). On the contrary, when cells were exposed to high doses of H # O # (1-5 mM), the levels of PKC activity were about the same in both the Plcg1 −/− and Plcg1 +/+ cells ( Figure 2B ). These observations showed that PKC activation in fibroblasts stimulated with low doses of H # O # was dependent on PLC-γ1.
H 2 O 2 -induced ERK1/ERK2 activation is PLC-γ1-independent
ERK is a crucial kinase for cell survival in many cell types [1] . In the present study, we examined the effect of PLC-γ1 and PKC on ERK1\ERK2 activation by treatment with H # O # . Plcg1 −/− and Plcg1 +/+ cells were treated with various concentrations of H # O # for 10 min, and the cell lysates were subjected to kinase assay as described in the Experimental section. ERK activity increased in a dose-dependent manner after stimulation with H # O # in both cell lines and there was no difference between wild-type and PLC-γ1-deficient cells (Figure 3 ). This implies that PLC-γ1 was not required for H # O # -induced ERK activation in MEF.
PLC-γ1 is involved in H 2 O 2 -induced Bcl-2 phosphorylation and negatively regulates caspase-3 activation
Bcl-2 plays an important role in cell survival in stress response, and phosphorylation of Bcl-2 at Ser(! may be required for its full and potent anti-apoptotic function [17] [18] [19] 29, 30] . To determine the role of H # O # in Bcl-2 phosphorylation and whether PLC-γ1 is involved in this process, Plcg1 −/− and Plcg1 +/+ cells were labelled with [$#P]orthophosphoric acid and then incubated with 
Figure 3 Effect of PLC-γ1 on ERK1/ERK2 activation by treatment with H 2 O 2
Plcg1 + / + and Plcg1 − / − MEF were treated with various doses of H 2 O 2 for 10 min and cell lysates were subjected to ERK1/ERK2 kinase assay as described in the Experimental section. We further investigated the relationship between caspase-3 activation and PLC-γ1 in oxidative stress. Following stimulation with 200 µM H # O # for 12 h, it was observed that caspase-3-like activity in Plcg1 −/− cells had increased considerably compared with that in wild types ( Figure 4B ). Western blot analysis of pro-Phospholipase C-γ1 is required for cell survival in oxidative stress
Figure 5 PLC-γ1 protects MEF from H 2 O 2 -induced cell death by PKC-dependent phosphorylation of Bcl-2 and inhibition of caspase-3
Plcg1 + / + and Plcg1 − / − MEF, untreated or pretreated with either 150 nM Bryostatin-1, a PKC activator, or 5 µM chelerythrine chloride, a PKC inhibitor, were incubated with 200 µM H 2 O 2 for 12 h. The activity of PKC (A), levels of Bcl-2 phosphorylation (B) and caspase-3 activation (C) were detected as described above. (D) Plcg1 + / + and Plcg1 − / − MEF untreated or pretreated either with 150 nM Bryostatin-1 or 5 µM chelerythrine chloride were incubated with 200 µM H 2 O 2 for 22 h, and cell viability was determined by the Trypan Blue dye-exclusion method. Results shown are the meanpS.E. for three independent experiments. Bryo, Bryostatin-1; Ch, chelerythrine chloride; Con, control.
caspase-3 also indicated that caspase-3 was cleaved into active form in Plcg1 −/− but little affected in Plcg1 +/+ ( Figure 4B ). These results suggest that PLC-γ1 plays an important role in the phosphorylation of Bcl-2 and inhibition of caspase-3 following oxidative stress.
Role of PKC
PKC plays an anti-apoptotic role in cellular response to some stress applications by phosphorylation of Bcl-2 and inhibition of caspase-3 activity [17] [18] [19] [20] [21] [22] . To determine whether effects of PLC-γ1 on Bcl-2 phosphorylation and caspase-3 activation in oxidative stress are PKC-dependent, we examined further the effects of PKC-specific inhibitor or activator on PKC activation, Bcl-2 phosphorylation, caspase-3 activation and cell viability in Plcg1 −/− and Plcg1 +/+ cells during oxidative stress. Results showed that pretreatment with 150 nM Bryostatin-1, a PKC activator, increased the activity of PKC, levels of Bcl-2 phosphorylation, cell viability and decreased caspase-3 activity in Plcg1 −/− cells following 200 µM H # O # treatment for 12 h ( Figure 5 ). Meanwhile, pretreatment with 5 µM chelerythrine chloride, a PKC inhibitor, decreased PKC activation, levels of Bcl-2 phosphorylation and cell viability and enhanced caspase-3 activity in Plcg1 +/+ cells ( Figure 5 ). These results suggest that PKC mediates PLC-γ1 protection of fibroblasts from oxidative stress-induced apoptosis by phosphorylation of Bcl-2 and inhibition of caspase-3.
DISCUSSION
In the present study, we have demonstrated that PLC-γ1 is activated in response to H # O # treatment by a PTK-dependent mechanism. In addition, by using Plcg1 −/− MEF as a system in which no endogenous PLC-γ1 is expressed, we have provided evidence that stimulation of PLC-γ1 is required for cell survival in oxidative-stress response and that PKC-dependent Bcl-2 phosphorylation and caspase-3 inhibition may be the downstream targets of PLC-γ1 in this process.
It is well established that tyrosine phosphorylation of PLC-γ1 is necessary for its activation and that PLC-γ1 undergoes phosphorylation on tyrosine residues in response to H # O # treatment [15, [31] [32] [33] . Our present study not only showed that PLC-γ1 is phosphorylated following H # O # treatment but also demonstrated that activities of PLC-γ1 measured by the total amount of inositol phosphates increased in a dose-and timedependent manner. On the other hand, the concentration of H # O # employed (as low as 200 µM) in this study was much lower than that of Qin et al. [31] , Blake et al. [32] and Schieven et al. [33] (in excess of 1 mM, and usually between 5 and 10 mM) and is consistent with the recent study by Wang et al. [15] using the same cell line. Survival of MEF deficient in PLC-γ1 function is severely compromised over the same dose response of H # O # ( Figure 5D ). Such observations suggest that H # O # is a strong activator of PLC-γ1 and the role of PLC-γ1 is protection of cells against H # O # -induced cell death. The mechanisms leading to PLC-γ1 phosphorylation in response to oxidant injury have been reported by Wang et al. [15] . They showed that H # O # -induced phosphorylation of PLC-γ1 in MEF could be blocked by pharmacological inhibitors of Srcfamily tyrosine kinases or the epidermal growth factor receptor tyrosine kinase, but not by inhibitors of platelet-derived growth factor receptor or PI-3K. In the present study, we also found that PLC-γ1 is stimulated in a tyrosine phosphorylation-dependent and PI-3K-independent manner following oxidative stress. However, we could not demonstrate which PTKs are involved in this process. It appears that PTKs such as epidermal growth factor receptor and Src-family tyrosine kinases may contribute to the activation of PLC-γ1 in oxidative stress.
A major conclusion of the present study is that PLC-γ1 plays a pro-survival role in the cellular response to acute oxidative stress by PKC. Consistent with our observations, Wang et al. [15] showed that pretreatment of Plcg1 +/+ MEF with inhibitors of PKC increased their sensitivity to H # O # , whereas treatment of Plcg1 −/− MEF with agents capable of directly activating PKC significantly improved their survival. However, they did not demonstrate whether PKC is stimulated by H # O # treatment and whether PLC-γ1 is required for PKC activation in oxidative stress. Our results showed that PKC activity increased in a timedependent manner after stimulation with 200 µM H # O # in wildtype cells, whereas the activation of PKC in PLC-γ1-deficient cells was completely abolished (Figure 2A ). On the contrary, when cells were exposed to high doses of H # O # (1-5 mM), the levels of PKC activity were about the same in both the Plcg1 −/− and Plcg1 +/+ cells ( Figure 2B ). These results strongly support the relevance of PKC activation and pro-survival role of PLC-γ1 in oxidative-stress response, but raise the question as to why the increase of PKC activity following high doses of H # O # treatment is PLC-γ1-independent. It is possible that the mechanisms leading to the activation of PKC by a high dose of H # O # are different from those initiated by low doses of H # O # . Several reports have demonstrated that PKC isoforms, including α, βΙ and γ of classical PKC, ε and δ of novel PKC and ζ of atypical PKC, are tyrosine phosphorylated and catalytically activated in a DAGindependent manner in the H # O # -treated (5 mM) cells [34] [35] [36] . Therefore PKC isoforms can be activated by tyrosine phosphorylation in cells treated with high doses of H # O # by using a mechanism unrelated to receptor-coupled hydrolysis of inositol phospholipids. Furthermore, the tyrosine phosphorylation sites of PKCδ in the 5 mM H # O # -treated cells are identified as Tyr-311, Tyr-322 and Tyr-512 [37] and this phosphorylation may facilitate the proteolytic activation of PKCδ by caspase-3 and promote apoptosis induced by anti-Fas-antibody and radiation [38, 39] . These findings are consistent with our result that both Plcg1 −/− and Plcg1 +/+ MEF died rapidly on stimulation with high doses (5 mM) of H # O # (results not shown). The role of PKC in cell death and apoptosis is well documented (for a review see [40] ). Promoting cell survival or apoptosis depends on specific PKC isoforms, the cell type, the state of activation of the cell, phase of the cell cycle and the nature of the agent used [40] . Our results demonstrated that PLC-γ1-dependent PKC activation in MEF is required for cell survival during oxidative stress and that PKC-dependent phosphorylation of Bcl-2 and inhibition of caspase-3 activity may be the downstream targets of PLC-γ1 survival signalling pathway. However, it remains to be determined which PKC isoenzyme(s) is involved in the regulation of PLC-γ1 survival signalling during the cellular response to oxidative stress.
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